Navigation Links
Wrigley Keeps Kids Smiling Through Donation to American Dental Association Program
Date:1/28/2008

Effort Encourages Americans to Help Kids Receive Care

CHICAGO, Jan. 28 /PRNewswire-FirstCall/ -- In honor of National Children's Dental Health Month this February, the Wm. Wrigley Jr. Company (NYSE: WWY) is donating $100,000 plus 10 percent of February gross sales in the U.S. (up to another $100,000) of Orbit(R), Extra(R) and Eclipse(R) sugar-free gums to Give Kids A Smile(R), an annual American Dental Association (ADA) program that provides free oral health education, screening and treatment services to hundreds of thousands of children in need.*

"For nearly 20 years Wrigley has championed the oral health benefits of chewing gum by sharing extensive clinical research results with dental professionals and consumers around the world. In September our long-standing commitment to oral health care was validated when Orbit, Extra and Eclipse became the first and only chewing gums in the U.S. to earn the trusted ADA Seal of Acceptance," said Paul Chibe, Wrigley's Vice President of North American Gum Marketing. "Sharing the ADA's passion and commitment to better oral care, we are happy to support the 'Give Kids A Smile' program."

According to the Centers for Disease Control and Prevention, although tooth decay is largely preventable, it is the most common chronic disease of children 5 to 17 years old in the U.S,(1) and it is estimated that 52 million class hours are missed every year in U.S. schools because of oral health problems that go untreated.(2)

Dr. Harvey Passes, a long-time practicing dentist who is teaming up with Wrigley to promote the importance of good oral care, says a unified effort is needed. "With the help of so many dentists who volunteer their time and the companies and individuals who financi
'/>"/>

SOURCE Wm. Wrigley Jr. Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Wrigleys Orbit(R), Extra(R) and Eclipse(R) Sugar-Free Chewing Gums Awarded American Dental Associations Seal of Acceptance
2. Protein that controls hair growth also keeps stem cells slumbering
3. U.S. Food Safety: The Import Alarm Keeps Sounding
4. Online Resource Keeps Restaurant Diners on Track After New Years Hype Subsides
5. Knowing Heart Risk Keeps Patients on Cholesterol Drugs
6. Obesity Keeps Patients From Needed CT Scans After Surgery
7. Video: Charmins Gift That Keeps on Giving!
8. Right breakfast bread keeps blood sugar in check all day
9. Mothers milk a gift that keeps on giving
10. No Sheet: New Disposable Cover Keeps Bed Bugs at Bay
11. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
...ter against cancer, has been conferred the honor o...ear-old pediatric radiologist, hailing from Leeds ...n she was only 26. Despite a mastectomy, the disea...g to her lungs and bones. It would get you this ti...
...the Atlantis space shuttle have completed a fourth...S), a spokesperson for the US National Aeronautics...ring the space walk, astronauts Patrick Forrester ...ate a Solar Alpha Rotary Joint (SARJ), allowing so...
...emiological studies to evaluate the recent increas...s significant impact on the nations health resour...erra-based clinical immunology and allergy physici...fold increase in demand for food allergy-related c...
... say that they have developed a faster, less expen...large, non-gene stretches of DNA. The development...s can result not only from mutant genes, but also ...trols genes. "Diseases are known to occur as a co...
Other Medicine News:Health News:42-year-old Cancer Patient Honored by British Queen for Her Fundraising Efforts 2Health News:Increase in the Rate of Food Allergy 2Health News:Boffins Develop New Technique to Hunt Illness-causing Mutants in Non-gene DNA 2
(Date:10/8/2008)...inical improvement in patients with pulmonary ...ent options have limited benefit for this debilita... vessel disease, -- Imatinib mesylate, availabl...ers, known to inhibit protein associated with PAH,...atinib mesylate in PAH in 2009 EAST HANOVER,...
(Date:10/7/2008)...wire/ -- The Texas Cardiac Arrhythmia,Institute (T...ed as one of,only a few sites in the nation to par...ew device to treat persistent atrial fibrillation....search center specializing in heart,rhythm disorde...enter and,Texas Cardiovascular Consultants., "Thi...
(Date:10/7/2008)...re-FirstCall/ -- CEL-SCI Corporation,(NYSE: CVM )...al Transfer,Agreement (MTA) with the National Inst...aboratory of Dr. Francesco M. Marincola, M.D., to,...tumor microenvironment,caused by CEL-SCI,s cancer ...Infectious Disease and Immunogentics Section, Depa...
(Date:10/7/2008)...ewswire/ -- Taligen Therapeutics Inc.,today announ...pipeline,candidates were presented at the XXII Int...nd. The data highlighted the candidates, efficacy ...seases., "These highlighted presentations, as wel...ference, reveal the deep expertise and expanding,k...
Breaking Medicine Technology:Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 2Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 3Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 4Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 5Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 6Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 7Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 8Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 9Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 10Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 11Early Data Show Potential for Imatinib Mesylate Tablets to Treat Life-Threatening Form of Pulmonary Artery Disease 12Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 2In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 3In Vivo Data on Taligen Therapeutics' Pipeline Candidates Presented at the XXII International Complement Workshop 4Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 1Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 2Indonesias Pharmaceutical companies Get Boost in Competitive Advantage from Launch of Newport Horizon Premium and IDRAC Solutions by Thomson Reuters 25770 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 1ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 2ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 3ORBIS and Alcon Train Chinas Next Generation of Sight Savers 7316 4Lilly and Amylin Set Date and Time for Conference Call 25766 1Lilly and Amylin Set Date and Time for Conference Call 25766 2AgriLife Research breeder develops drought tolerant corn 4604 1AgriLife Research breeder develops drought tolerant corn 4604 2
...OURNE, Australia & MENLO PARK, Calif.--(BUSINE... (ASX: CXS, NASDAQ: CXSP) notes,the publication of...ategy for Ceflatonin(R) (homoharringtonine). The p...hiladelphia-positive leukemias",by researchers Sim...ologna, Italy (Haematologica Volume 92, pages 401-...
...New product recently approved by FDA for long-term...; data demonstrate,first nebulized formoterol fuma... dry powder formoterol, enhanced patient quality o...(May 20, 2007) – Data presented at the,Inter...ty (ATS),demonstrate that Perforomist™ (form...
Other Medicine Technology:Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 2Independent Publication Confirms Growing Therapeutic Challenge of,T315I Mutation in Patients with CML, Notes ChemGenex 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7
Laser hair removal for all skin types, including tanned skin. Used for leg and facial veins, non-invasive skin treatment. Offers a large spot sizes with high repetition rates for fast treatment. A
The Soft THORACOPORT™ has a cannula that is less rigid from a side to side perspective than the standard THORACOPORT™ , ,THORACOPORT™ devices are trocars used to gain access to th
These are the Reusable Components (minus cannula), to be used with the VersaStep™ Plus Reposable Short System.
VersaStep™ Reposable Sterilization Trays.
Medicine Products: